Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Nov 17, 2025 · Filed Nov 19, 2025
Synchrony Financial's See remarks sold $1.46M of Synchrony Financial shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,456,000
Shares × reported transaction price
33 days after results of Oct 15, 2025, 71 days before results of Jan 27, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $70.47 on Nov 17, 2025, 61% above its 52-week low and 8% below its high, after a 1% drop over the previous 30 trading days
52-week range $43.81 (Apr 4, 2025) to $76.86 (Sep 4, 2025), 81% of the way up, from 250 adjusted closes. 30 trading days earlier: $71.38 on Oct 6, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +7.1% | +4.7% | +2.3% |
| 30 days | +18.8% | +5.0% | +13.9% |
| 90 days | +0.8% | +5.2% | -4.3% |
| 180 days | -4.0% | +12.4% | -16.4% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
